Clinical Trial Update: A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures [Phase 2]

View source ↗

Summary

A completed Phase 2 safety and efficacy follow-up trial of Levetiracetam in children aged 4-17 with absence seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Seizures

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Absence Seizures | Phase 2 | Status: COMPLETED